AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15552361 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiarization with a diamond appearing in distinct locations to the left or right of a vertical bar
Number of subjects: 0
Study 15552361 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiarization with a diamond appearing in distinct locations with a bar oriented at 45 degrees
Number of subjects: 0
Study 15552361 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiment 4 (not detailed in the abstract)
Number of subjects: 0
Study 11881062 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (ARB)
Number of subjects: 92
Study 11881062 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (ACE-I)
Number of subjects: 92
Study 11881062 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs (Candesartan cilexetil and Lisinopril)
Number of subjects: 92
Study 9781600 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy combined with cisplatin and 5-fluorouracil
Number of subjects: 70
Study 9781600 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 70
Study 7824815 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation 2 litres/min through a catheter placed in the vestibulum nasi (Group 2a)
Number of subjects: 160
Study 7824815 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation 2 litres/min through a pharyngeal catheter (Group 2b)
Number of subjects: 160
Study 7824815 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation 3 litres/min through a pharyngeal catheter (Group 3)
Number of subjects: 160
Study 7824815 — intervention group
Group type: COMPARATOR
Intervention: No oxygen supplementation (Group 1)
Number of subjects: 160
Study 3043354 — intervention group
Group type: EXPERIMENTAL
Intervention: roxithromycin (150 mg bd)
Number of subjects: 193
Study 3043354 — intervention group
Group type: COMPARATOR
Intervention: erythromycin ethylsuccinate (1 g bd)
Number of subjects: 193
Study 3043354 — intervention group
Group type: EXPERIMENTAL
Intervention: roxithromycin
Number of subjects: 193
Study 3043354 — intervention group
Group type: COMPARATOR
Intervention: erythromycin ethylsuccinate
Number of subjects: 193
Study 31544377 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm acupuncture at specific acupuncture points (Zhongwan, Qihai, Guanyuan, Zhongji, Guilai, Zigong, Zusanli, Sanyinjiao) for 60 min, once a day, for 5 times with 2 days interval, for 3 consecutive courses until embryo transfer.
Number of subjects: 29
Study 31544377 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm acupuncture (as above)
Number of subjects: 29
Study 31544377 — intervention group
Group type: COMPARATOR
Intervention: Fresh leonurus japonicus capsule, 0.8 g, 3 times a day for 7 days, for 3 courses until embryo transfer.
Number of subjects: 29
Study 28689295 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory rTMS (1-Hz, 20-min session) applied over the left somatosensory cortex
Number of subjects: 13
Study 28689295 — intervention group
Group type: COMPARATOR
Intervention: Sham protocol
Number of subjects: 13
Study 25770704 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 109
Study 25770704 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 109
Study 25770704 — intervention group
Group type: COMPARATOR
Intervention: Sleep Seminar (SS)
Number of subjects: 109
Study 23648075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous supply of omega-3 PUFAs (EPA and DHA)
Number of subjects: 20
Study 23648075 — intervention group
Group type: COMPARATOR
Intervention: Control group (without omega-3 PUFAs)
Number of subjects: 20
Study 21614496 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg) twice daily for 3 months followed by CC/HMG/HCG for 3 months
Number of subjects: 30
Study 21614496 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months followed by CC/HMG/HCG for 3 months
Number of subjects: 30
Study 18221256 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab (1 mg/kg infusion 2 hours before transplantation and then every 14 days for four more doses)
Number of subjects: 36
Study 18221256 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus-based therapy without daclizumab (historical control group)
Number of subjects: 36
Study 18221256 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 36
Study 17722304 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 10% vitamin C derivative (VC-PMG)
Number of subjects: 20
Study 17722304 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 5% vitamin E
Number of subjects: 20
Study 17722304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12923149 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic adhesiolysis plus intrauterine application of ACP gel (10 ml)
Number of subjects: 92
Study 12923149 — intervention group
Group type: COMPARATOR
Intervention: Operative hysteroscopy alone (control group)
Number of subjects: 92
Study 10699646 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded vascular autonomic control (head-up tilt at various angles)
Number of subjects: 20
Study 9123741 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant androgen suppression prior to radiation therapy
Number of subjects: 0
Study 9123741 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 0
Study 8245333 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography
Number of subjects: 190
Study 3898846 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Mu/M2 interferon
Number of subjects: 68
Study 3898846 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Mu/M2 interferon
Number of subjects: 68
Study 3898846 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 Mu/M2 interferon
Number of subjects: 68
Study 28988549 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU (treatment as usual) plus low‐intensity CBT‐Music (treatment)
Number of subjects: 28
Study 28988549 — intervention group
Group type: COMPARATOR
Intervention: TAU alone (control)
Number of subjects: 28
Study 24618370 — intervention group
Group type: EXPERIMENTAL
Intervention: UrgoStart® (hydroactive dressing containing nano-oligosaccharide factor)
Number of subjects: 0
Study 24618370 — intervention group
Group type: COMPARATOR
Intervention: UrgoCell® Contact (neutral foam dressing without NOSF)
Number of subjects: 0
Study 24618370 — intervention group
Group type: EXPERIMENTAL
Intervention: UrgoStart®
Number of subjects: 0
Study 24618370 — intervention group
Group type: COMPARATOR
Intervention: UrgoCell® Contact
Number of subjects: 0
Study 25262251 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Monitoring (RM) with Biotronik ICD (Lumax VR‐T or Lumax DR‐T)
Number of subjects: 416
Study 25262251 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Monitoring (RM)
Number of subjects: 416
Study 25262251 — intervention group
Group type: COMPARATOR
Intervention: Standard-care follow‐up
Number of subjects: 416
Study 24645535 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II compression stockings for six months
Number of subjects: 80
Study 24645535 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 80
Study 20842006 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 needles
Number of subjects: 36
Study 20842006 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 needles
Number of subjects: 36
Study 18411039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochrane reviews (drug interventions)
Number of subjects: 157
Study 18411039 — intervention group
Group type: EXPERIMENTAL
Intervention: DARE reviews (drug interventions)
Number of subjects: 157
Study 18411039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochrane reviews (adverse events)
Number of subjects: 157
Study 18411039 — intervention group
Group type: EXPERIMENTAL
Intervention: DARE reviews (adverse events)
Number of subjects: 157
Study 16151060 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmaz Genesis Peripheral Stent (Cordis)
Number of subjects: 52
Study 12913326 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture containing acetyl‐L‐carnitine (ALC), polyunsaturated fatty acids (PUFAs), coenzyme Q10 (CoQ10) and vitamin E
Number of subjects: 14
Study 12913326 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E only (control group)
Number of subjects: 14
Study 10873918 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy alone
Number of subjects: 61
Study 10873918 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment (adding a selective serotonin reuptake inhibitor)
Number of subjects: 61
Study 9199588 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral B Ortho toothbrushes
Number of subjects: 20
Study 9199588 — intervention group
Group type: COMPARATOR
Intervention: Oral B Plus 35 toothbrushes
Number of subjects: 20
Study 1549027 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (10 mg, oral dose)
Number of subjects: 12
Study 1549027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 4077364 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg metoprolol (i.v.)
Number of subjects: 0
Study 4077364 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.30 mg/kg metoprolol (i.v.)
Number of subjects: 0
Study 4077364 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment with slow-release metoprolol (1 X 200 mg/day for 4 weeks)
Number of subjects: 0
Study 4077364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30376962 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (10 mg/kg)
Number of subjects: 68
Study 30376962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 27153745 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg E4/DRSP
Number of subjects: 396
Study 27153745 — intervention group
Group type: COMPARATOR
Intervention: E2V/DNG (control)
Number of subjects: 396
Study 27153745 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg E4/LNG
Number of subjects: 396
Study 27153745 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-3.8% absence of withdrawal bleeding
Number of subjects: 396
Study 27153745 — intervention group
Group type: EXPERIMENTAL
Intervention: 14.0-18.5% absence of withdrawal bleeding
Number of subjects: 396
Study 24706588 — intervention group
Group type: EXPERIMENTAL
Intervention: Black raspberry (750 mg/day)
Number of subjects: 77
Study 22464728 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of affect recognition (TAR)
Number of subjects: 40
Study 22464728 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual including occupational therapy (TAU)
Number of subjects: 40
Study 22166634 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored loading dosage of clopidogrel
Number of subjects: 205
Study 22166634 — intervention group
Group type: COMPARATOR
Intervention: Rational loading dosage of clopidogrel
Number of subjects: 205
Study 22166634 — intervention group
Group type: COMPARATOR
Intervention: Talcom group (domestic clopidogrel)
Number of subjects: 205
Study 22166634 — intervention group
Group type: COMPARATOR
Intervention: Plavix group
Number of subjects: 205
Study 18654784 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent-protected angioplasty
Number of subjects: 2973
Study 18654784 — intervention group
Group type: COMPARATOR
Intervention: Surgery (carotid endarterectomy)
Number of subjects: 2973
Study 11286312 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended treatment with dalteparin for 3 months after initial treatment
Number of subjects: 1000
Study 11286312 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive therapy
Number of subjects: 1000
Study 11286312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 9412548 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol 50 micrograms
Number of subjects: 35
Study 9412548 — intervention group
Group type: COMPARATOR
Intervention: Albuterol 400 micrograms
Number of subjects: 35
Study 8501151 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg)
Number of subjects: 24
Study 8501151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3429872 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide (5 mg once daily)
Number of subjects: 12
Study 3429872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30317262 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dose of 10mg of 0.5% hyperbaric bupivacaine (Group A)
Number of subjects: 80
Study 30317262 — intervention group
Group type: COMPARATOR
Intervention: Height and weight-adjusted dose of 0.5% hyperbaric bupivacaine (Group B)
Number of subjects: 80
Study 26889801 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless Goal Management Training (GMT), n=33
Number of subjects: 67
Study 26889801 — intervention group
Group type: COMPARATOR
Intervention: Conventional Goal Management Training (GMT), n=34
Number of subjects: 67
Study 26889801 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Errorless GMT and Conventional GMT)
Number of subjects: 67
Study 25690005 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 251
Study 25690005 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline for 12 weeks
Number of subjects: 251
Study 23594786 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine-cisplatin plus cetuximab
Number of subjects: 904
Study 23594786 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine-cisplatin alone
Number of subjects: 904
Study 19394599 — intervention group
Group type: EXPERIMENTAL
Intervention: Single lymphocytes from sibling cell lines and blastomeres from sibling day 3 human embryos evaluated using whole genome amplification and single‐nucleotide polymorphism microarrays.
Number of subjects: 6
Study 19394599 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐blastomere DNA fingerprinting technology.
Number of subjects: 6
Study 18837604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (group and individual)
Number of subjects: 45
Study 18837604 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 45
Study 16635073 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized recruitment letter including information about blood type and donation statistics
Number of subjects: 0
Study 16635073 — intervention group
Group type: COMPARATOR
Intervention: General recruitment letter with some general information
Number of subjects: 0
Study 14613676 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT(2) antagonists (clozapine or olanzapine)
Number of subjects: 50
Study 10969665 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted dissector (group A, n = 31)
Number of subjects: 92
Study 10969665 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-coupled retractor (group B, n = 31)
Number of subjects: 92
Study 10969665 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (group C, n = 30)
Number of subjects: 92
Study 9065277 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 65
Study 9065277 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 65
Study 1466849 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone (100mg orally twice weekly)
Number of subjects: 98
Study 1466849 — intervention group
Group type: COMPARATOR
Intervention: Pentamidine (400 mg nebulized monthly)
Number of subjects: 98
Study 1466849 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone
Number of subjects: 98
Study 1466849 — intervention group
Group type: COMPARATOR
Intervention: Pentamidine
Number of subjects: 98
Study 31535100 — intervention group
Group type: EXPERIMENTAL
Intervention: 11-mm-long implants combined with maxillary sinus floor elevation
Number of subjects: 38
Study 31535100 — intervention group
Group type: COMPARATOR
Intervention: 6-mm-long implants without any grafting
Number of subjects: 38
Study 31535100 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 28522762 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmeal exercise with metformin
Number of subjects: 10
Study 28522762 — intervention group
Group type: COMPARATOR
Intervention: Metformin/sedentary
Number of subjects: 10
Study 28522762 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin/exercise
Number of subjects: 10
Study 28522762 — intervention group
Group type: COMPARATOR
Intervention: Washout/sedentary
Number of subjects: 10
Study 28522762 — intervention group
Group type: EXPERIMENTAL
Intervention: Washout/exercise
Number of subjects: 10
Study 27235761 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Reminiscence Approach - Reality Orientation (GRA-RO)
Number of subjects: 94
Study 27235761 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity
Number of subjects: 94
Study 27235761 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Training
Number of subjects: 94
Study 27235761 — intervention group
Group type: EXPERIMENTAL
Intervention: GRA-RO
Number of subjects: 94
Study 24464385 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal video‐assisted cholecystectomy (TVC)
Number of subjects: 97
Study 24464385 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 97
Study 23020699 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use polyvinyl chloride laryngeal mask airway
Number of subjects: 72
Study 23020699 — intervention group
Group type: COMPARATOR
Intervention: Single-use silicone laryngeal mask airway
Number of subjects: 72
Study 19755082 — intervention group
Group type: EXPERIMENTAL
Intervention: Steel scalpel incision
Number of subjects: 19
Study 19755082 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery blade incision
Number of subjects: 19
Study 18675519 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (1mg/kg daily, max 100mg)
Number of subjects: 60
Study 18675519 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (5mg for >40kg, 10mg for 40-60kg, 20mg for >60kg)
Number of subjects: 60
Study 18675519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 15970897 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive patch (ethinyl estradiol [EE] 20 microg/d and norelgestromin 150 microg/d)
Number of subjects: 24
Study 15970897 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive (EE 35 mug and norgestimate 250 microg)
Number of subjects: 24
Study 12878917 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone and acamprosate (16 weeks of active treatment)
Number of subjects: 1375
Study 12878917 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Management (9 brief sessions)
Number of subjects: 1375
Study 12878917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Behavioral Intervention (up to 20 sessions)
Number of subjects: 1375
Study 12878917 — intervention group
Group type: COMPARATOR
Intervention: No-pill psychotherapy-alone condition
Number of subjects: 1375
Study 10474019 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/day ipriflavone
Number of subjects: 60
Study 10474019 — intervention group
Group type: COMPARATOR
Intervention: 0.8 g/day calcium lactate
Number of subjects: 60
Study 8695365 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine administered as a 24 h infusion at a maximum tolerated dose (MTD) of 180 mg m‐2 on days 0, 7, and 14, repeated every 28 days.
Number of subjects: 24
Study 8695365 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine administered as a 24 h infusion at various dose levels (10, 20, 40, 80, 120, 180, and 210 mg m‐2).
Number of subjects: 24
Study 8695365 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum tolerated dose of gemcitabine.
Number of subjects: 24
Study 1878329 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% solution of mineralizing agent and 0.2% NaF solution
Number of subjects: 123
Study 1878329 — intervention group
Group type: COMPARATOR
Intervention: Placebo and 0.2% NaF solutions
Number of subjects: 123
Study 6346847 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide (2.5 mg/day)
Number of subjects: 0
Study 6346847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31665070 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-WP-MPH (marine protein hydrolysate)
Number of subjects: 14
Study 31665070 — intervention group
Group type: COMPARATOR
Intervention: CHO-WP (whey protein and carbohydrate)
Number of subjects: 14
Study 29020831 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoendoscopic single-site surgery (LESS)
Number of subjects: 60
Study 29020831 — intervention group
Group type: COMPARATOR
Intervention: Minilaparoscopy (ML)
Number of subjects: 60
Study 27497840 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP (Exposure and Response Prevention)
Number of subjects: 37
Study 23881116 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured training group (SG)
Number of subjects: 15
Study 23881116 — intervention group
Group type: COMPARATOR
Intervention: Flexible training group (FG)
Number of subjects: 15
Study 23881116 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart-rate recovery in FG
Number of subjects: 15
Study 23881116 — intervention group
Group type: COMPARATOR
Intervention: Heart-rate recovery in SG
Number of subjects: 15
Study 22518835 — intervention group
Group type: EXPERIMENTAL
Intervention: 30%‐3
Number of subjects: 18
Study 22518835 — intervention group
Group type: EXPERIMENTAL
Intervention: 80%‐1
Number of subjects: 18
Study 22518835 — intervention group
Group type: EXPERIMENTAL
Intervention: 80%‐3
Number of subjects: 18
Study 22518835 — intervention group
Group type: EXPERIMENTAL
Intervention: 80%‐1 and 80%‐3
Number of subjects: 18
Study 19789191 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous low dose dexamethasone (4 mg initial dose, followed by 2 mg every 8 hours for 24 hours)
Number of subjects: 200
Study 19789191 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 200
Study 17553993 — intervention group
Group type: EXPERIMENTAL
Intervention: Right anodal/left cathodal DLPFC tDCS
Number of subjects: 0
Study 17553993 — intervention group
Group type: EXPERIMENTAL
Intervention: Left anodal/right cathodal DLPFC tDCS
Number of subjects: 0
Study 17553993 — intervention group
Group type: COMPARATOR
Intervention: Unilateral DLPFC stimulation (anodal tDCS over right or left DLPFC)
Number of subjects: 0